HDAC9 and cardiac hypertrophy: Specifically, the pan HDAC inhibitor TSA blunted cardiac hypertrophy and improved systolic function in a pressure-overload transverse aortic constriction model in mice [7] and TSA was even capable of reversing pre-existing hypertrophy [19].